CONGRESS PROGRAM
Consisting of lectures, symposia and poster sessions, the scientific program will provide an intensive focus on the pathogenesis of human and animal diseases. Under the Congress theme « Gene-environment interaction in health and disease », special emphasis will be placed on diseases, technologies, tools and novel therapeutic approaches.
Topics Include
I-Pathophysiological pathways of health and diseases
Ageing - Cancer - Cardiovascular, hypertension and renal diseases - Diabetes, Obesity, Metabolic syndrome and endocrine diseases - Gastrointestinal diseases - Inflammation, infection and immune system diseases - Lung diseases - Neurodegenerative diseases and pain - Regenerative medicine
II-Novel pathophysiological approaches and tools
Novel animal models - “Omics” tools including Genomics, Transcriptomics, Proteomics, Ecogenomics, Epigenomics and Pharmacogenomics - Systems biology and signal transduction
III. Novel therapeutic/diagnostic pathophysiological targets
Biomarkers and molecular diagnosis - Drug targets -Therapeutic targets-Diseasome
Invited Speakers: Plenaries, Symposia, Workshops
The 6th International Congress of Pathophysiology and the 14th International SHR Symposium will feature an exciting program of plenary sessions and a diverse array of parallel sessions and other opportunities to participate in emerging discussions. More information on plenaries will appear on this site as the program evolves.
Keynote Speakers
- Allen ATTIE, University of Wisconsin,
Madison, USA
Novel pathophysiological approaches and tools: Systems biology and signal transduction - Albert L. BARABASI, Northeastern University,
Boston USA
Diseasome - Giuseppe BIANCHI, Department of Science and Biomedical Technology State University of Milan, Milan, ITALY
Use of rat networks to understand human networks - Michel BOUVIER, Université de Montréal, Montréal, CANADA
Therapeutic targets - Pierre CORVOL, Collège de France, Paris, FRANCE
Vasculature as an integrator of diseases - Allen W. COWLEY, Medical College of Wisconsin,
Milwaukee, USA
Novel animal models and genetic modification techniques in the rat - Alan DENG, Centre de recherche du CHUM Université de Montréal, Montréal, CANADA
Use of rat networks to understand human networks - Anna DOMINICZAK, Glasgow Cardiovascular Research Center, Glasgow, UK
Novel pathophysiological approaches and tools: Systems biology and signal transduction - Victor DZAU, Duke Medicine,
Durham, USA
Regenerative Medicine of cardiovascular diseases - Aron M. GEURTS, Medical College of Wisconsin, Wisconsin, USA
Novel animal models and genetic modification techniques in the rat - Richard E. GILBERT,University of Toronto, Toronto, CANADA
Novel diabetic therapeutic pathways - Qide HAN, Peking University,
Beijing, CHINA
Systems Biology - Norbert HÜBNER, Max Delbrück Center for Molecular Medicine Berlin, Berlin, GERMANY
Metabonomics of cardiometabolic diseases - Hiroshi ITOH, Keio University School of Medicine, Tokyo, JAPAN
Aldosterone and Hypertension - Shokei KIM-MITSUYAMA, Kumamoto University Graduate School of Medical Sciences, Kumamoto, JAPAN
Aldosterone and Hypertension - Jaroslav KUNES, Institute of Experimental Medicine Prague, Prague, CZECH REPUBLIC
Novel pathophysiological approaches and tools: Gene-environment interactions including epigenomics and environmental exposure - Bernard LÉVY, Institut National de la santé et de la recherche médicale, Paris, FRANCE
Regenerative Medicine of cardiovascular diseases - Peter LIU, Toronto General Hospital, Toronto, CANADA
Therapeutic targets - Tak W. MAK, Princess Margaret Hospital,
Toronto, CANADA
Pathophysiological pathways: Metabolism and Cancer - Tomoji MASHIMO, Kyoto University, Kyoto, JAPAN
Regenerative medicine of cardiovascular diseases - Bruce MCMANUS, St. Paul’s Hospital, UBC James Hogg Research Center, Vancouver, CANADA
Biomarkers and Drug targets - Marju MELANDER, Malmö University Hospital, Malmö, SWEDEN
Biomarkers and drug targets - John MULLINS, Centre for Cardiovascular Science University of Edinburgh, Edinburgh, UK
Application of genome technologies for rat and human genetics - Monica NERI, National Cancer Research Institute Largo Rosanna,
Genoa, ITALY
Pathophysiological pathways: Lung diseases - Tommy NILSSON, McGill University, Montréal, CANADA
Novel pathophysiological approaches and tools: Omics tools including genomics, trancriptomics, proteomics and pharmacogenomics
- Michal PRAVENEC, Institute of Physiology Academy of Sciences of the Czech Republic, Prague, CZECH REPUBLIC
Novel animal models and genetic modification techniques in the rat - Mark Prentki, Centre de Recherche du CHUM, Montréal, CANADA
Novel diabetic therapeutic pathways
- Allen D. ROSES, Duke University,
Durham, USA
Pharmacogenomics in Drug Discovery - Guy ROULEAU, Hôpital Ste Justine,
Montréal, CANADA
Pathophysiological pathways: Neurodegenerative disease and pain
- Rafik SÉKALY, Hôpital Saint-Luc du CHUM,
Montréal, CANADA
Pathophysiological pathways: Inflammation, infection and immune system diseases - Kazuaki SHIMAMOTO, Sapporo Medical University, Sapporo, JAPAN
Pathophysiological pathways: Gastrointestinal diseases - Moshe SZYF, McGill University,
Montréal, CANADA
Novel pathophysiological approaches and tools: Gene-environment interactions including epigenomics and environmental exposure - Miyako TAKAKI, Nara Medical University, Kashihara, JAPAN
Pathophysiological pathways: Gastroinstestinal diseases - Yoram YAGIL, Laboratory for Molecular Medicine & Israel Rat Genome Center Ben-Gurion University, Ashkelon, ISRAEL
Novel pathophysiological approaches and tools: Gene-environment interactions including epigenomics and environmental exposure
- Barry ZIRKIN, John Hopkins School of Public Health,
Baltimore, USA
Pathophysiological Pathways: Ageing
Workshop 1: Impact of environmental exposures on the reproductive system
Vassilios PAPADOPOULOS, Health Center Research, McGill University, Montreal, CANADA
- Jacob DE BOER, Institute of Environmental Studies, VU University, Amsterdam, THE NETHERLANDS
- Kevin GAIDO, The Hamner Institutes for Health Sciences, Washington, USA
- Gail S. PRINS, Department of Physiology and Biophysics, University of Illinois, Chicago, USA
Workshop 2: Cell volume regulation
Vladimir STRBAK, Slovak Academy of Sciences, Bratislava, SLOVAKIA
- Else Kay HOFFMANN, University of Copenhagen, Copenhagen, DENMARK
- Yasunobu OKADA, Okazaki National Research Institutes, Okazaki, JAPAN
- Sergei N. ORLOV (University of Montreal, Montreal, Canada)
- Markus PAULMICHL, Verona University, Verona, ITALY
- Markus RITTER, Austrian Academy of Sciences, Vienna, AUSTRIA
Workshop 3: Dietary salt, cardiotonic steroids, hypertension and renal disease
Alexei BAGROV, National Institute on Aging, NIH, Baltimore, USA
- Frans H. LEENEN, Heart Institute, University of Ottawa, Ottawa, CANADA
- David LICHSTEIN, Hebrew University of Jerusalem, Jerusalem, ISRAEL
- Jerry B. LINGREL, University of Cincinnati, College of Medicine, Cincinnati, USA
- John N. LORENZ, University of Cincinnati, College of Medicine, Cincinnati, USA
- Joseph I. SHAPIRO, University of Toledo, College of Medicine, Toledo, USA
- Zi-Jian XIE, University of Toledo, College of Medicine, Toledo, USA
Workshop 4: Epithelial Mesenchymal Transition/Organ fibrosis and the myofibrolast
Lászlo ROSIVAL, Institute of Pathophysiology, Semmelweis University, Budapest, HUNGARY
Andras KAPUS, St. Michael’s Hospital, Toronto, CANADA
- Harold CHAPMAN, University of California, San Francisco, USA
- Anna Mae DIEHL, Duke University of Medicine, Durham, USA
- Boris HINZ, École Polytechnique Fédérale de Lausanne, Lausanne, SWITZERLAND
- Yeesim KHEW-GOODALL, Hanson Institute IMVS, Adelaide, AUSTRALIA
- William SCHNAPER, Northwestern University, Chicago, USA
- Michael ZEISBERG, Harvard University, Cambridge, USA
Workshop 5: Pathophysiological Mechanism relating to unspecific back pain – an update
Osmo HÄNNINEN, University of Kuopio, Kuopio, FINLAND
Hans-Christoph SCHOLLE, Jena University Hospital, Jena, GERMANY
Christoph ANDERS, Friedrich-Schiller-Universität, Jena, GERMANY
- Olavi AIRAKINSEN, University of Kuopio, Kuopio, FINLAND
- Martin S.FISCHER, Friedrich-Schiller-Universität, Jena, GERMANY
- R. FRÖBER, Institut für Anatomie, Friedrich-Schiller-Universität, Jena, GERMANY
- R. GRIESHABER, Mannheim, GERMANY
- Bettina HESSE, Friedrich-Schiller-Universität, Jena, GERMANY
- Claudine J.C. LAMOTH, Institute for Fundamental and Clinical Human Movement Sciences, Faculty of Human Movement Sciences, Amsterdam, THE NETHERLANDS
- Nadja SCHILLING, Friedrich-Schiller-Universität, Jena, GERMANY
- H. STARK, Friedrich-Schiller-Universität, Jena, GERMANY
- H. WAGNER, Münster, GERMANY
Workshop 6: Purinergic Signaling in Health and Disease
Ryszard GRYGORCZYK, Centre de recherche du CHUM, Université de Montréal, Montréal, CANADA
- Nickolai DULIN (University of Chicago, Chicago, USA)
- John W. HANRAHAN, Health Center Research, McGill University, Montreal, CANADA
- Eduardo R. LAZAROWSKI, University of North Carolina at Chapel Hill, Chapel Hill, USA
- Alexander A. MONGIN, Albany Medical College, Albany, USA
- Jean SÉVIGNY, Université Laval, Montréal, CANADA
Workshop 7: Dysfunction of glial cells in neuronal pathologies
Alexander A. MONGIN, Albany Medical College, Albany, USA
- Sandra J. HEWITT, Health Center, University of Connecticut, Farmington, USA
- Trevor OWENS, University of Southern Denmark, Odense, DENMARK
- Serge RIVEST, Laboratory of Molecular Endocrinology, Université Laval, Montreal, CANADA
- Nancy J. ROTHWELL, University of Manchester, Manchester, UK
- Lyanna C. SCHLICHTER, University of Toronto, Toronto, CANADA
Poster Sessions
Poster sessions are being provided to offer a further means of sharing information from colleagues
from around the globe regarding past experiences, new ideas and innovations . Posters will be grouped by themes and sub-themes and presented in the exhibition
hall for the duration of the Congress.
Specific sessions will allow author(s) to present their posters and interact with other
Congress participants. More information will come as the website will evolve.